A novel imidazopyridine derivative, X22, attenuates sepsis-induced lung and liver injury by inhibiting the inflammatory response in vitro and in vivo.
about
A novel imidazopyridine derivative, X22, attenuates sepsis-induced lung and liver injury by inhibiting the inflammatory response in vitro and in vivo.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A novel imidazopyridine deriva ...... response in vitro and in vivo.
@en
A novel imidazopyridine deriva ...... response in vitro and in vivo.
@nl
type
label
A novel imidazopyridine deriva ...... response in vitro and in vivo.
@en
A novel imidazopyridine deriva ...... response in vitro and in vivo.
@nl
prefLabel
A novel imidazopyridine deriva ...... response in vitro and in vivo.
@en
A novel imidazopyridine deriva ...... response in vitro and in vivo.
@nl
P2093
P2860
P356
P1476
A novel imidazopyridine deriva ...... response in vitro and in vivo.
@en
P2093
Guang Liang
Hongjin Chen
Tingting Xu
Xiangting Ge
Xiaoou Shan
Yali Zhang
Yuanrong Dai
P2860
P304
P356
10.2147/DDDT.S101449
P407
P577
2016-06-30T00:00:00Z